The ISC aims to advance the education and the science of therapy of infection and of cancer through the establishment of an international federation of affiliated national and regional societies with similar aims and objectives to its own. The ISC currently has a worldwide membership composed of 85 national and regional societies, which in turn have over 50,000 individual members. The Member Societies hold
their own congresses which are supported by the ISC.
The ISC promotes the conduct of scientific research, convening international congresses, conferences and symposia and encourages co-operation within the society and between scientists belonging to other societies dealing with related basic and clinical sciences. In the last decade, most of the society work has been on antimicrobials.
The ISC currently has 17 Working Groups / Sections and actively encourages and/or sponsors the formation of international working groups for special research, training projects or the use of therapeutics in the field of anti-infective and anti-neoplastic therapy and co-ordinating their activities. The Working Groups contribute significantly to the ISC Disease Management Series of meetings. In addition, the ISC awards scholarships and bursaries to enable attendance at and travel to its international congresses.The Society is governed by its Trustees, Executive Committee and Council which are led by Professor Teresita Mazzei, ISC President. The ISC Council consists of representatives of ISC Member
Societies and meets at least every two years during the ICCs.
The Society’s official journal is the International Journal of Antimicrobial Agents and Chemotherapy (IJAA). It recently saw an increase in Impact Factor to over 3 under the expert guidance of the Editor-in-Chief: Professor Alasdair Geddes. |